It is generally injected under the skin in your abdomen, thigh, or upper arm
By application, the type 2 diabetes mellitus segment led the global GLP-1 receptor agonist market in 2025
Challenges in bariatric surgery: outcomes in patients having three or more bariatric procedures
GLP-1 receptor agonists are complex peptide chains with much higher molecular weights, which means they cross the sublingual membrane more slowly and less completely
3 To understand the relationship between GLP-1 medications and kidney function, as measured by creatinine lab results, we studied 108,439 adult patients who started semaglutide, liraglutide, or tirzepatide between 2021 and 2024 and had one or more creatinine labs in the months leading up to and following the new medication
Generic Injectable Semaglutide approved in South Africa Following the March patent expirations, generic manufacturing continues to spread globally